From: The Epoch Times [4]
Health Canada 's approval last July of a vaccine that protects women from a common from of cervical cancer may have been premature, say experts.
Canada's record for treatment of cervical cancer is adequate, they say, and fast-tracking Gardasil, a vaccine for Human Papilloma Virus (HPV), isn't the way to go. $300 million has been allotted to the vaccine program from the recent federal budget.
But health professionals are questioning the necessity of a HPV vaccine in countries like Canada , which have successful comprehensive cervical screening programs.
More>>> [5]
04/19/07